Lopinavir
Showing 1 - 25 of 551
High-Grade Anal Intraepithelial Neoplasia Trial in Madison (Lopinavir / Ritonavir)
Not yet recruiting
- High-Grade Anal Intraepithelial Neoplasia
- Lopinavir / Ritonavir
-
Madison, WisconsinUW Digestive Health Center Anoscopy Clinic
Jan 12, 2023
Hodgkin Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage II Adult Hodgkin Lymphoma Trial in Rochester (drug, genetic, other)
Withdrawn
- Hodgkin Lymphoma
- +4 more
- lopinavir
- +5 more
-
Rochester, MinnesotaMayo Clinic
Nov 28, 2022
Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19
Completed
- Coronavirus
- +2 more
-
Doha, QatarHamad Medical Corporation
Aug 15, 2022
Tolerability of Lopinavir Versus Dolutegravir for Children and
Recruiting
- HIV
-
Maseru, Lesotho
- +1 more
Jul 25, 2022
Coronavirus Infections, Post-exposure Prophylaxis Trial in Vancouver, Toronto (Lopinavir/ritonavir)
Active, not recruiting
- Coronavirus Infections
- Post-exposure Prophylaxis
-
Vancouver, British Columbia, Canada
- +3 more
Nov 29, 2021
Healthy Volunteers Trial in Austin (Pitavastatin (NK-104), Lopinavir/ritonavir)
Completed
- Healthy Volunteers
- Pitavastatin (NK-104)
- Lopinavir/ritonavir
-
Austin, Texas(unnamed)
Jun 9, 2021
COVID-19, Hospitalized COVID-19 Patients Trial in Zgharta, Tripoli (Lopinavir / Ritonavir, Remdesivir (RDV), Tocilizumab)
Recruiting
- COVID-19
- Hospitalized COVID-19 Patients
- Lopinavir / Ritonavir
- +3 more
-
Zgharta, North, Lebanon
- +1 more
Jun 28, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial
Withdrawn
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- Lopinavir/Ritonavir
- +2 more
- (no location specified)
Apr 22, 2021
HIV Trial in Baltimore (Lopinavir/Ritonavir)
Terminated
- HIV
-
Baltimore, MarylandUniversity of Maryland, Institute of Human Virology
Jan 20, 2022
Covid19 Trial in Bani Suwayf (Remdesivir, Lopinavir/ Ritonavir and Remdesivir combination)
Recruiting
- Covid19
- Remdesivir
- Lopinavir/ Ritonavir and Remdesivir combination
-
Banī Suwayf, EgyptBeni-suef University
Mar 15, 2021
HIV Trial in Cincinnati (Truvada (tenofovir/emtricitabine), Kaletra (lopinavir/ritonavir))
Completed
- HIV Infections
- Truvada (tenofovir/emtricitabine)
- Kaletra (lopinavir/ritonavir)
-
Cincinnati, OhioUniversity of Cincinnati AIDS Clinical Trials Unit
Jul 14, 2022
COVID-19 Trial in United States (Lopinavir/Ritonavir 400 mg/100 mg, Placebo)
Active, not recruiting
- COVID-19
- Lopinavir/Ritonavir 400 mg/100 mg
- Placebo
-
Aurora, Colorado
- +5 more
Aug 17, 2022
HIV Trial in Puerto Rico, United States (Abacavir sulfate, lamivudine, and zidovudine, Lamivudine/zidovudine,
Completed
- HIV Infections
- Abacavir sulfate, lamivudine, and zidovudine
- +2 more
-
Los Angeles, California
- +7 more
Oct 28, 2021
(PK) Study of Efavirenz or Lopinavir/Ritonavir Between Older and
Completed
- HIV Infections
- Blood drawing to determine drug levels
-
Bronx, New YorkJacobi Medical Center ACS Clinic
Apr 22, 2021
HIV Trial in Nijmegen (Lopinavir/ritonavir)
Completed
- HIV Infections
-
Nijmegen, Gelderland, NetherlandsRadboud University Medical Centre
Nov 9, 2020
Fixed Dose Combination of Lopinavir/Ritonavir in Human
Terminated
- HIV-1 Infection
-
Kazan, Tatarstan, Respublika, Russian Federation
- +9 more
Jul 1, 2021
COVID-19, Coronavirus Infection, Virus Disease Trial in Belo Horizonte, Betim, Ouro Preto (Hydroxychloroquine Sulfate Tablets,
Recruiting
- COVID-19
- +4 more
- Hydroxychloroquine Sulfate Tablets
- +3 more
-
Belo Horizonte, Minas Gerais, Brazil
- +3 more
Jan 25, 2021
Bioequivalence Trial in Akyurt, Sahinbey (Lopinavir/Ritonavir 200 mg/50 mg Film Tablet, Lopinavir/Ritonavir 200 mg/50 mg Film
Completed
- Bioequivalence
- Lopinavir/Ritonavir 200 mg/50 mg Film Tablet
- Lopinavir/Ritonavir 200 mg/50 mg Film Coated Tablet
-
Akyurt, Ankara, Turkey
- +1 more
Nov 23, 2020